The abstract is read at the publisher; the summary is JClub's.
Nuclear OXCT1 reduces MHC-I gene transcription by suppressing histone β-hydroxybutyrylation in hepatocellular carcinoma cells.
- Why it matters: Understanding how metabolic factors influence immunotherapy responses is crucial, as current knowledge remains limited. Identifying mechanisms that modulate immune gene expression could improve treatment strategies.
- What they did: The study used multiomics analysis of HCC tumor biopsies and found that increased OXCT1 expression correlates with decreased ICB efficacy, while its substrate BHB has the opposite effect; mechanistically, glucose deprivation promotes nuclear translocation of OXCT1, which interacts with IRF1 to suppress histone H3K9 BHB at immune gene loci.
- The result: Targeting the AMPK-OXCT1-IRF1 pathway enhances tumor sensitivity to ICB, suggesting that nuclear OXCT1's regulation of ketone body metabolism and immune gene transcription influences immunotherapy outcomes.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.